Skip to main content
. 2020 Oct 17;103:103497. doi: 10.1016/j.jdent.2020.103497

Table 1.

Dental hard tissue diseases and procedures where CHX could be used under current UK guidelines and narrative review of recent published evidence.

Key causative microbes Formulation Supporting information
Dental caries Streptococcus Mutans Not recommended May reduce prevalence of S. Mutans and amount of gingival plaque, but unlikely to reduce incidence of dental caries
Lactobacillus Early indications mouthwash may result in more acid saliva and microbiome shift to caries causing bacteria
Orthodontics See dental caries Not recommended See dental caries
Pre-extraction Mixed Not recommended Pre-rinsing no beneficial effect on any subsequent bacteraemia
Post-extraction Mixed Not recommended Saltwater mouth rinse preferred post-operatively
Dry socket None - inflammatory 0.12 or 0.2% daily mouthwash Evidence to support use as oral rinse pre- or post-extraction, may have benefit on reducing clinical symptoms
MRONJ None - inflammatory Not recommended Most recent guidelines, not recommended in UK prior to extraction
Outside UK 0.12% or 0.2% daily mouthwash may be used to manage stage 1 symptoms of MRONJ
Root canal procedures Enterococcus faecalis (most persistent) 0.2 - 2% peri-operative irrigant May have some benefit on pathogens causative for persistent periodontal periodontitis after root canal therapy, but hydrogen peroxide considered superior
Bacterial aerosolisation Mixed 10 ml of 0.12 or 0.2% mouthwash for 1 minute prior to procedure Reduces aerosolisation by 70-90%